Abiopharma

RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting

Dominari Holdings Issues Letter to Shareholders

New Form SCHEDULE 13G - Quoin Pharmaceuticals, Ltd. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001716774-26-000006 <b>Size:</b> 8 KB

Integer Holdings Corporation - Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities During MD&M West 2026

Calidi Biotherapeutics - Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

McKesson Corporation - McKesson Corporation Declares Quarterly Dividend

Natera - Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain

New Form F-1/A - AKANDA CORP. <b>Filed:</b> 2026-01-28 <b>AccNo:</b> 0001213900-26-008630 <b>Size:</b> 200 KB

General Announcement: Changes to the Composition of the Board of Directors and Board Committees

Change - Announcement of Cessation: Resignation of Independent Director

Change - Announcement of Appointment: Appointment of Independent Director

BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation